| Prognostic factors |
Univariate analysis |
Multivariate analysis |
| Age |
0.052 |
0.879 |
| Sex |
0.811 |
0.584 |
| Alpha fetoprotein |
0.676 |
0.079 |
| Liver cirrhosis |
0.494 |
0.426 |
| Portal vein thrombosis |
0.001* |
0.599 |
| Total serum bilirubin |
0.001* |
0.168 |
| Serum albumin |
0.001* |
0.789 |
| Alkaline phosphatase |
0.479 |
0.366 |
| Serum AST |
0.002* |
0.975 |
| Serum ALT |
0.001* |
0.965 |
| Prothrombin time |
0.001* |
0.168 |
| Viral marker |
0.001* |
0.879 |
| Tumor size |
0.296 |
0.407 |
| Extra hepatic metastases |
0.595 |
0.002* |
| BCLC |
0.352 |
0.051* |
| Anti p53 antibody |
0.001`* |
0.001* |
| MIF |
0.001* |
0.022* |
| Treatment (yes/no) |
0.767 |
0.033* |
| Type of treatment |
0.247 |
0.876 |
|
